Trial
NCT05408910
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
Nationwide Children's Hospital; University of Minnesota; University of Texas Southwestern Medical Center
Condition
Cystic Fibrosis
Intervention
Rifaximin 550 MG Oral Tablet [XIFAXAN]
Why stopped
new drug formulation by the manufacturer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-27